Healthcare
Monday, August 22, 2016
BRIEF-Gilead Sciences - European Commission grants marketing authorization for Truvada
* European Commission grants marketing authorization for
Gilead's once-daily Truvada for reducing the risk of sexually
acquired HIV-1
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment